Halo Collective Stock Price, News & Analysis
Company Description
Halo Collective (OTC Link: HCANF) is a publicly traded drug manufacturers - specialty & generic company in the Healthcare sector. The company has a market capitalization of $15.1K.
HCANF stock has gained 0.0% over the past year. Shares last traded at $0.0000.
This page provides a comprehensive overview of HCANF stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Halo Collective (HCANF) stock last traded at $0.0000. At a market capitalization of $15.1K, HCANF is classified as a micro-cap stock with approximately 120.5M shares outstanding.
Latest News
Halo Collective has 10 recent news articles. Of the recent coverage, 4 articles coincided with positive price movement and 4 with negative movement. Key topics include earnings, acquisition, management. View all HCANF news →
SEC Filings
Financial Highlights
Upcoming Events
Short Interest History
Short interest in Halo Collective (HCANF) currently stands at 1 shares, representing 0.0% of the float. This relatively low short interest suggests limited bearish sentiment. With 1000.0 days to cover, it would take significant time for short sellers to close their positions based on average trading volume.
Days to Cover History
Days to cover for Halo Collective (HCANF) currently stands at 1000.0 days, up 99899% from the previous period. This elevated days-to-cover ratio indicates it would take over two weeks of average trading volume for short sellers to exit their positions, suggesting potential for a short squeeze if positive news emerges. The ratio has shown significant volatility over the period, ranging from 1.0 to 1000.0 days.
HCANF Company Profile & Sector Positioning
Halo Collective (HCANF) operates in the Drug Manufacturers - Specialty & Generic industry within the broader Healthcare sector and is listed on the OTC Link.
Investors comparing HCANF often look at related companies in the same sector, including Item 9 Labs (INLB), Veritas Farms (VFRM), Onassis Holdings Corp (ONSS), Bloomios Inc (BLMS), and Avivagen (VIVXF). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate HCANF's relative position within its industry.